Cell–Cell Interactome-Based Pathogenesis and Therapies for Osteosarcoma

TL;DR

This review explains how interactions between osteosarcoma cells and their surrounding environment drive cancer progression and resistance to treatment, suggesting new therapeutic strategies.

Contribution

The paper provides a comprehensive synthesis of tumor-microenvironment interactions in osteosarcoma and identifies novel therapeutic strategies based on these mechanisms.

Findings

Tumor-microenvironment interactions involving endothelial cells, fibroblasts, and immune cells drive osteosarcoma progression and therapy resistance.

Exosome communication, immune evasion, and vascular remodeling are key mechanisms contributing to osteosarcoma aggressiveness.

Targeting these interactions could improve treatment outcomes through precision medicine and microenvironment-focused therapies.

Abstract

What are the main findings?
The review systematically summarizes how tumor–microenvironment interactions, involving endothelial cells, fibroblasts, stromal cells, immune populations, and osteoclasts, drive osteosarcoma metastasis, therapy resistance, and tumor progression.Key molecular and cellular mechanisms, including exosome communication, signaling pathway activation, immune evasion, and vascular remodeling, are identified as central contributors to osteosarcoma aggressiveness.

The review systematically summarizes how tumor–microenvironment interactions, involving endothelial cells, fibroblasts, stromal cells, immune populations, and osteoclasts, drive osteosarcoma metastasis, therapy resistance, and tumor progression.

Key molecular and cellular mechanisms, including exosome communication, signaling pathway activation, immune evasion, and vascular remodeling, are identified as central contributors to osteosarcoma aggressiveness.

What are the implications of the main findings?
Understanding these cellular crosstalk mechanisms provides a foundation for developing targeted therapies, immunomodulatory strategies, and microenvironment-focused interventions to overcome therapy resistance and metastatic spread.The integrated insights from this review support precision medicine approaches, highlight actionable molecular targets, and guide future research to improve the clinical management of osteosarcoma.

Understanding these cellular crosstalk mechanisms provides a foundation for developing targeted therapies, immunomodulatory strategies, and microenvironment-focused interventions to overcome therapy resistance and metastatic spread.

The integrated insights from this review support precision medicine approaches, highlight actionable molecular targets, and guide future research to improve the clinical management of osteosarcoma.

Osteosarcoma (OS), the most common primary malignant bone tumor in children and young adults, is characterized by aggressive behavior, frequent metastasis, and resistance to chemotherapy, resulting in poor clinical outcomes. Increasing evidence indicates that OS progression is not solely driven by tumor-intrinsic factors but is strongly influenced by dynamic interactions within the tumor microenvironment (TME). This literature review synthesizes current research on the roles of endothelial cells, fibroblasts, mesenchymal stromal cells, immune populations, and osteoclasts in OS pathogenesis, with emphasis on cell–cell interactions mediated by direct contact, soluble factors, and extracellular vesicles. The studies demonstrate that these interactions promote tumor proliferation, immune evasion, extracellular matrix remodeling, metastatic dissemination, and therapeutic resistance. Adaptive responses of both tumor and stromal cells to environmental stressors contribute to chemoresistance and disease progression. Collectively, our findings highlight the multifactorial nature of OS driven by complex cellular crosstalk within the TME. Understanding these mechanisms highlights the limitations of conventional chemotherapy and encourages the development of combined therapeutic approaches, including targeted therapies, immunomodulation, and microenvironmental interventions. Continued investigation into tumor–microenvironment interactions may facilitate the identification of actionable targets and improve personalized treatment approaches for OS.

Figures